Psychedelic Assisted Therapies

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Healthcare Workers Back Psychedelics But Lack Crucial Knowledge, Study Finds
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Numinus Wellness Sells US Clinics, Partners With Stella For Tech-Driven Mental Health Solutions
New Study Charts Adverse Events In Psychedelic-Assisted Therapies

Psychedelic Assisted Therapies Recent News

Relaxation Emerges As Strongest Predictor Of Psychedelic Therapy Benefits, Study
Study reveals relaxation, not mystical experiences, as the main factor in the success of psychedelic therapy for treatment-resistant depression.
U.S. Election Stress Fuels Demand For Psychedelic-Assisted Therapy
Post-election stress has driven a surge in Americans seeking psychedelic therapy for relief, with clinics reporting record appointments.
Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing
Veterans seeking PTSD relief face legal challenges in accessing psychedelic therapies. Will these treatments become available to those in need?
UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis
A UK-funded study will explore psilocybin's potential to treat opioid addiction, with a focus on reducing high relapse rates.
California College Launches Nation's First Psychedelic Studies Degree For Undergraduates
CIIS launches the first undergraduate degree in psychedelic studies, training students to meet the demand for therapeutic expertise.
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
Pro golfers are using psychedelics like psilocybin and DMT to sharpen mental performance, signaling a new trend in sports wellness.
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
Joe Rogan and Elon Musk discuss the pharma industry's history of prioritizing profits over health, sparking debate on drug safety and ethics.
2024 Election Spotlight: Massachusetts And Oregon Tackle Psychedelics Reform
MA and OR voters decide on groundbreaking psychedelic policies in 2024, with measures that could redefine mental health treatment nationwide.
Cannabist Co. Joins Forces With 'Weed For Warriors' In Veterans Day Cannabis Donation Drive
Cannabist Company partners with Weed for Warriors to support veteran access to medical cannabis through a Veterans Day donation drive across 12 U.S. states.
JD Vance Considers Psychedelic Therapy For Vets: Insights From Joe Rogan Interview
JD Vance's discussed his views on therapeutic psychedelics for veterans, and his "live and let live" approach to drug policy.
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
Compass Pathways delays key Phase 3 psilocybin trial readouts, triggering a 30% workforce reduction amid efforts to conserve cash and refocus.
FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care
Eliza Dushku Pushes For Psychedelics Legalization In Massachusetts - A Personal Journey, A Public Cause
Eliza Dushku advocates for legalizing psychedelics in Massachusetts, sharing her experience with therapy and calling for regulated access.
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
Global psychedelic drugs market to reach $10.2 billion by 2028, driven by mental health needs and evolving regulatory support.
Psychedelic Drug DOI Pinpoints Anxiety Circuits Avoiding Hallucinogenic Effects, Study Finds
New study shows how psychedelic DOI reduces anxiety by targeting specific neurons, potentially paving the way for non-hallucinogenic anxiety treatments.
Ireland's First Psychedelic Conference Explores Substances As Mental Health Treatment
Ireland's first psychedelics conference at Trinity College highlights potential mental health benefits of hallucinogens.
Beyond The Brain: Heart Activity May Shape Psychedelic Experiences, Study Finds
New study links DMT-induced mystical experiences to unique heart activity patterns, suggesting that psychedelics' profound effects may extend beyond the brain.
A Roadmap To Healing: First-Ever Veterans' Guide To Psychedelics Now Available
The Veteran's Guide to Psychedelics offers veterans practical strategies for exploring psychedelic therapy to heal PTSD, anxiety, and depression.
Ukraine's Military Veterans Turn To Ketamine For PTSD Treatment As Advocacy Grows
Ketamine therapy is providing fast relief for PTSD in Ukraine's military veterans, offering new hope for the war-torn nation's emotional recovery.
How Psychedelic Experiences Affect Couples: New Study Looks Into It
Imperial College London is recruiting couples for a study on how shared psychedelic experiences, such as MDMA, impact relationship intimacy, communication and satisfaction.
News Hampshire Lawmakers Reject Psychedelics Bill Citing Safety Concerns Though Support Continued Research
New Hampshire lawmakers reject a bill to establish therapeutic psychedelic centers, citing concerns over legality and the bill's broad scope.
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
Awakn Life Sciences partners with the University of Nottingham to advance in vivo testing of its aminoindane therapy for PTSD, with results expected by late 2024.
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
Enveric Biosciences announces positive preclinical results for EB-003, showcasing its potential as a safe and effective treatment for mental health disorders.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved